G. Walmsley Graham
CIK 1777517 · last filed 2025-12-09
G. Walmsley Graham is a corporate insider who has filed 37 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for AKRO, was dated Dec 9, 2025. Across all open-market trades the lifetime net is +$61.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $19.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$19.34M
3
37
$60.96M
Holdings By Company
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Disp (D) | −1,302,398 | $0 | EDGAR |
| 2025-10-10 | Akero Therapeutics, Inc. (AKRO) Delisted | Exer (M) | +90,832 | $1.87M | EDGAR |
| 2025-06-13 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +9,398 | $0 | EDGAR |
| 2025-05-13 | OLMA | — | — | $0 | EDGAR |
| 2025-03-27 | Akero Therapeutics, Inc. (AKRO) Delisted | Buy (P) | +200,000 | $8.79M | EDGAR |
| 2025-02-07 | Akero Therapeutics, Inc. (AKRO) Delisted | Buy (P) | +200,000 | $9.60M | EDGAR |
| 2024-12-18 | OLMA | Mixed | — | $0 | EDGAR |
| 2024-12-17 | OLMA | Mixed | −1,401,522 | -$9.46M | EDGAR |
| 2024-11-26 | OLMA | Sell (S) | −1,175,000 | -$17.45M | EDGAR |